The Role of the Matrix Metalloproteinase-9 Gene in Tumor Development and Metastasis: A Narrative Review
- PMID: 37077369
- PMCID: PMC10110361
- DOI: 10.1055/s-0043-1768166
The Role of the Matrix Metalloproteinase-9 Gene in Tumor Development and Metastasis: A Narrative Review
Abstract
Matrix metalloproteinase-9 (MMP-9) is one of the widely studied enzymes of the extracellular matrix which can degrade various matrix biomolecules. The gene coding for this enzyme has been found to be associated with various multifactorial diseases, including cancer. More specifically, the expression of MMP-9 and polymorphisms of its gene have been found to be correlated with the formation and the invasiveness of different types of cancer. Hence, the latter gene can potentially be used both as a clinical genetic marker and a possible target in anticancer therapy. The present minireview explores the role of the MMP-9 gene in the process of tumor formation, growth, and metastasis and presents an overview of the polymorphisms of the gene associated with cancer as well as its regulation mechanisms, to provide an insight into the potential clinical applications. Nevertheless, further clinical trials and research are still required to reach more valuable conclusions for the clinical implications of the recent findings.
Keywords: MMP-9; carcinogenesis; matrix metalloproteinases; metastasis; oncogenes.
The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. ( https://creativecommons.org/licenses/by/4.0/ ).
Conflict of interest statement
Conflict of Interest None declared.
Figures
Similar articles
-
Matrix metalloproteinase inhibitors.Invest New Drugs. 1997;15(1):61-75. doi: 10.1023/a:1005722729132. Invest New Drugs. 1997. PMID: 9195290 Review.
-
Roles of matrix metalloproteinase-7 (MMP-7) in cancer.Clin Biochem. 2021 Jun;92:9-18. doi: 10.1016/j.clinbiochem.2021.03.003. Epub 2021 Mar 10. Clin Biochem. 2021. PMID: 33713636 Review.
-
Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.J Nutr Biochem. 2006 May;17(5):356-62. doi: 10.1016/j.jnutbio.2005.08.009. Epub 2005 Sep 19. J Nutr Biochem. 2006. PMID: 16214327
-
Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.Eur J Med Chem. 2020 May 15;194:112260. doi: 10.1016/j.ejmech.2020.112260. Epub 2020 Mar 21. Eur J Med Chem. 2020. PMID: 32224379 Review.
-
Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.Curr Med Chem. 2023;30(18):2075-2112. doi: 10.2174/0929867329666220823112731. Curr Med Chem. 2023. PMID: 36017851 Review.
Cited by
-
Synthesis, in vitro and in silico studies of a novel chrysin-ferrocene Schiff base with potent anticancer activity via G1 arrest, caspase-dependent apoptosis and inhibition of topoisomerase II.J Enzyme Inhib Med Chem. 2025 Dec;40(1):2501377. doi: 10.1080/14756366.2025.2501377. Epub 2025 May 21. J Enzyme Inhib Med Chem. 2025. PMID: 40396612 Free PMC article.
-
Lymph node transcriptomic profiles suggest susceptibility to bleomycin-induced pulmonary toxicity in classic hodgkin lymphoma.Sci Rep. 2025 Aug 18;15(1):30273. doi: 10.1038/s41598-025-16218-8. Sci Rep. 2025. PMID: 40826186 Free PMC article.
-
Targeting Neuronal Nitric Oxide Synthase (nNOS) as a Novel Approach to Enhancing the Anti-Melanoma Activity of Immune Checkpoint Inhibitors.Pharmaceutics. 2025 May 24;17(6):691. doi: 10.3390/pharmaceutics17060691. Pharmaceutics. 2025. PMID: 40574005 Free PMC article.
-
Anoikis-related genes predicts prognosis and therapeutic response in renal cell carcinoma.Ann Med. 2025 Dec;57(1):2548042. doi: 10.1080/07853890.2025.2548042. Epub 2025 Aug 19. Ann Med. 2025. PMID: 40830065 Free PMC article.
-
USP9X inhibits metastasis in pulmonary sarcomatoid carcinoma by regulating epithelial-mesenchymal transition, angiogenesis and immune infiltration.Transl Oncol. 2024 Sep;47:101950. doi: 10.1016/j.tranon.2024.101950. Epub 2024 Jul 3. Transl Oncol. 2024. PMID: 38964032 Free PMC article.
References
-
- Vandooren J, Van den Steen P E, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade. Crit Rev Biochem Mol Biol. 2013;48(03):222–272. - PubMed
-
- Hangauer D G, Monzingo A F, Matthews B W. An interactive computer graphics study of thermolysin-catalyzed peptide cleavage and inhibition by N-carboxymethyl dipeptides. Biochemistry. 1984;23(24):5730–5741. - PubMed
-
- Zhang J, Wang S, He Y, Yao B, Zhang Y. Regulation of matrix metalloproteinases 2 and 9 in corneal neovascularization. Chem Biol Drug Des. 2020;95(05):485–492. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous